At the end of a trying day, Chris Froome defended himself against the now public adverse analytical finding (AAF) for excessive amounts of asthma medicine salbutamol that threatens to see his Vuelta a España victory annulled.
On September 7, 2017, Froome dropped his main rival Vincenzo Nibali on the final ascent to Alto de Santo Toribio de Liébana of stage 18, recouping 21 of the 42 seconds he lost on the previous stage to extend his race lead to 1:37.
But his urine sample taken that day showed twice the allowed limit of the asthma drug salbutamol, a result confirmed by the B-sample analysis. In the video interview by the BBC, Froome seemed confident in defending himself to the UCI.
ADVERTISEMENT
"I can understand a lot of people’s reactions, especially given the history of the sport. I think this is obviously a very different case. This is not a positive test," Froome stated.
"As it stands the UCI have asked me for more information regarding my use of salbutamol, which is a very common medicine used for treating asthma. I think all the asthmatics out there will know what salbutamol is.
"Obviously I've only been too happy to try and help the UCI fill in the blanks there and to give all that information up, along with the team, to try and get to the bottom of what happened here.
- Chris Froome returns adverse analytical finding for salbutamol
- Will Chris Froome's salbutamol result sink Team Sky?
- Vuelta a Espana organisers call for 'extreme caution' after Froome salbutamol result
- Nibali: Chris Froome salbutamol case is terrible for the sport
You can read more at Cyclingnews.com
via Cyclingnews Latest News http://ift.tt/2o1BeVm
No comments:
Post a Comment